Geode Capital Management »

Adicet Bio Ord shares owned by Geode Capital Management

Quarter-by-quarter ownership of Adicet Bio Ord (ACET) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Adicet Bio Ord

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio Ord held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio Ord by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $748k 89k 8.42

More positions owned by Geode Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Meta Platforms Inc-class A Cl A (META)
Alphabet Inc-cl C Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc-cl B Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Visa Inc-class A Shares Com Cl A (V)
Johnson & Johnson (JNJ)
Mastercard Inc - A Cl A (MA)

View all positions for Geode Capital Management

Top funds holding Adicet Bio Ord

OrbiMed Advisors
RA Capital Management
Franklin Resources
Woodline Partners
Vanguard Group
Adage Capital Partners GP
Prosight Management
Renaissance Technologies
Goldman Sachs Group
Stonepine Capital Management
Alyeska Investment Group
Carlyle
Acadian Asset Management
Two Sigma Investments
ADAR1 Capital Management

View all funds holding Adicet Bio Ord